Literature DB >> 6304227

Treponema pallidum receptor binding proteins interact with fibronectin.

K M Peterson, J B Baseman, J F Alderete.   

Abstract

Analysis of plasma proteins avidly bound to T. pallidum surfaces revealed the ability of T. pallidum to acquire numerous host macromolecules. No acquisition was evident by the avirulent spirochete, T. phagedenis biotype Reiter. Western blotting technology using hyperimmune antifibronectin serum as a probe revealed the ability of virulent treponemes to avidly bind fibronectin from a complex medium such as plasma. The specificity of the tiplike adherence of motile T. pallidum to fibronectin-coated glass surfaces and to fibronectin on HEp-2 cells was reinforced by the observation that pretreatment of coverslips or cell monolayers with monospecific antiserum against fibronectin substantially reduced T. pallidum attachment. The stoichiometric binding of T. pallidum to fibronectin-coated coverslips and the inability of unlabeled or 35S-radiolabeled treponemes to interact with glass surfaces treated with other plasma proteins further established the specific nature of the interaction between virulent T. pallidum and fibronectin. The avid association between three outer envelope proteins of T. pallidum and fibronectin was also demonstrated. These treponemal surface proteins have been previously identified as putative receptor-binding proteins responsible for T. pallidum parasitism of host cells. The data suggest that surface fibronectin mediates tip-oriented attachment of T. pallidum to host cells via a receptor-ligand mechanism of recognition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304227      PMCID: PMC2187047          DOI: 10.1084/jem.157.6.1958

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  The use of freeze-preserved treponemes in the Treponema pallidum immobilization test.

Authors:  E E Nell; P H Hardy
Journal:  Cryobiology       Date:  1972-10       Impact factor: 2.487

3.  Protein synthesis by Treponema pallidum extracted from infected rabbit tissue.

Authors:  J B Baseman; N S Hayes
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

4.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

Review 5.  Immunity in syphilis.

Authors:  G R Cannefax
Journal:  Br J Vener Dis       Date:  1965-12

6.  Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.

Authors:  N H Bishop; J N Miller
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

7.  Parasitism by virulent Treponema pallidum of host cell surfaces.

Authors:  N S Hayes; K E Muse; A M Collier; J B Baseman
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

8.  Prolonged survival of virulent Treponema pallidum (Nichols strain) in cell-free and tissue culture systems.

Authors:  A H Fieldsteel; F A Becker; J G Stout
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

9.  Development of of macrophage migration inhibition in rabbits infected with virulent Treponema pallidum.

Authors:  C S Pavia; J D Folds; J B Baseman
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

10.  A radioimmunoassay of cellular surface antigens on living cells using iodinated soluble protein A from Staphylococcus aureus.

Authors:  G Dorval; K I Welsh; H Wigzell
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

View more
  57 in total

1.  Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.

Authors:  C Signäs; G Raucci; K Jönsson; P E Lindgren; G M Anantharamaiah; M Höök; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Characterization of a novel family of fibronectin-binding proteins with M23 peptidase domains from Treponema denticola.

Authors:  C V Bamford; T Francescutti; C E Cameron; H F Jenkinson; D Dymock
Journal:  Mol Oral Microbiol       Date:  2010-12       Impact factor: 3.563

4.  Affinities of Treponema pallidum for human lactoferrin and transferrin.

Authors:  J F Alderete; K M Peterson; J B Baseman
Journal:  Genitourin Med       Date:  1988-12

5.  Putative Treponema pallidum cytadhesins share a common functional domain.

Authors:  D D Thomas; J B Baseman; J F Alderete
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Interactions of fibronectin with Treponema pallidum.

Authors:  T J Fitzgerald; L A Repesh
Journal:  Genitourin Med       Date:  1985-06

7.  Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen.

Authors:  T E Fehniger; A M Walfield; T M Cunningham; J D Radolf; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum.

Authors:  D L Cox; P Chang; A W McDowall; J D Radolf
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.

Authors:  R E Baughn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Isolation and characterization of fibronectin-binding sites of Borrelia garinii N34.

Authors:  P A Kopp; M Schmitt; H J Wellensiek; H Blobel
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.